Malta vs Slovenia: HIV/AIDS deaths averted by antiretroviral therapy
Malta
37.73 deaths
in 2024
Slovenia
36.62 deaths
in 2024
Malta rank
140th
Slovenia rank
141st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Malta
- Slovenia
How they compare
Malta currently reports 37.73 deaths against 36.62 deaths in Slovenia, a difference of 1.11 deaths.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Slovenia ahead.
Malta ranks 140th and Slovenia ranks 141st of 157 countries.
Across the 4 decades both report, Malta averaged higher in 1 and Slovenia in 3.
Head to head by decade
| Decade | Malta | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0.7306 deaths | 0.7306 deaths | Slovenia |
| 2000s | 7.82 deaths | 10.07 deaths | 2.25 deaths | Slovenia |
| 2010s | 21.94 deaths | 22.1 deaths | 0.1672 deaths | Slovenia |
| 2020s | 34.89 deaths | 34.57 deaths | 0.316 deaths | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Malta or Slovenia?
- Malta, at 37.73 deaths against 36.62 deaths in Slovenia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Malta and Slovenia?
- 1.11 deaths, with Malta ahead.
- How many years of comparable data are there for Malta and Slovenia?
- 35 years are reported by both, from 1990 to 2024.
- How do Malta and Slovenia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Malta ranks 140th and Slovenia ranks 141st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.